- letzte 200 News
- Archiv
| Zeit | Aktuelle Nachrichten | Rating | Leser | ||
|---|---|---|---|---|---|
| 01.09. | Altron - Mixed performance in H126 | 343 | For H126, Altron has seen the benefit of a diversified portfolio in a challenging market environment. The IT Services business has suffered from constrained IT budgets and price pressure, with an operating... ► Artikel lesen | ||
| 01.09. | CLIQ Digital - Pressing the pause button | 768 | CLIQ Digital no longer intends to delist or to carry out a partial share buyback, and has withdrawn current year financial guidance. This uncertainty stems from policy changes by the group's payment... ► Artikel lesen | ||
| 01.09. | Basilea Pharmaceutica - Gearing up for the next growth phase | 437 | Basilea's H125 results reflected strong sales traction, with revenues up 36.3% y-o-y to CHF104m, underpinned by 21.7% growth in royalties. A key strategic milestone was the US launch of Zevtera, diversifying... ► Artikel lesen | ||
| 29.08. | OSE Immunotherapeutics - Spotlight on OSE's diverse clinical pipeline | 339 | OSE Immunotherapeutics has made tangible progress across its clinical development pipeline, creating positive momentum, in our view. In immuno-inflammation, monoclonal antibody therapy lusvertikimab... ► Artikel lesen | ||
| 28.08. | Filtronic - Record order from SpaceX | 387 | Hot on the heels of a $32.5m/£24.0m order in June, SpaceX has just placed a $62.5m/£47.3m order, the highest yet. This is for E-band solid-state power amplifiers (SSPAs) manufactured using gallium nitride... ► Artikel lesen | ||
| 28.08. | Nabaltec - Subdued H125 despite strong structural growth | 654 | Nabaltec recorded subdued results in H125, due to an increasingly challenging market environment, with both revenue and EBIT decreasing 1.7% and 18.5% y-o-y, respectively, to €106.5m and €8.9m. Despite... ► Artikel lesen | ||
| 28.08. | Murray International Trust - Delivering what it says on the tin | 258 | Murray International Trust's (MYI's) co-managers, Martin Connaghan and Samantha Fitzpatrick at Aberdeen Group, are encouraged by the trust's H125 results. During this volatile period in global markets... ► Artikel lesen | ||
| 28.08. | Alzinova - Innovative new approach to Alzheimer's | 330 | Alzinova is a Sweden-based clinical-stage biopharmaceutical company seeking to advance treatments for Alzheimer's disease (AD) via protein modification and immunotherapy-based solutions. Alzinova's... ► Artikel lesen | ||
| 27.08. | DUG Technology - Significant boost to order intake in H225 | 322 | DUG Technology's FY25 results confirmed that order intake stepped up in H225, with intake of $45.7m 131% higher half-on-half, resulting in a record order book of $52m at the end of the year. While revenue... ► Artikel lesen | ||
| 27.08. | Topps Tiles - Laying the groundwork for higher growth | 318 | Topps Tiles' (TPT's) diversification into larger addressable markets with more trading brands means it is well-placed to service more products to more customers in more sectors, and with greater efficiency... ► Artikel lesen | ||
| 27.08. | Oncopeptides - Targeted oncology with commercial momentum | 333 | Oncopeptides (ONCO) is a Swedish biotech that aims to develop and commercialise therapies for difficult-to-treat cancers, with a focus on haematological diseases. Its lead product, Pepaxti, was approved... ► Artikel lesen | ||
| 26.08. | Oryzon Genomics - Foray into sickle cell disease | 337 | Oryzon Genomics has announced that the European Medicines Agency (EMA) has provided regulatory clearance for a Phase Ib trial of iadademstat in sickle cell disease. The Phase Ib study (named RESTORE)... ► Artikel lesen | ||
| 26.08. | ProCredit Holding - More cautious amid macroeconomic uncertainty | 786 | ProCredit Holding (PCB) continues to make good progress in building the scale of its loan book, with 7.2% growth in H125 at constant currency (on track to meet management's FY25 guidance of c 12%).... ► Artikel lesen | ||
| 26.08. | The Platform Group - Robust revenue growth and margin delivery | 460 | The Platform Group (TPG) delivered robust growth in H125 as it continues to benefit from a greater presence in more verticals, with more partners (+26% y-o-y) and ultimately serving more customers (+29%).... ► Artikel lesen | ||
| 22.08. | Verve Group - Short-term impacts of platform unification | 748 | Verve Group's Q225 results show year-on-year growth slowing to 10% (-4% organic), from 32% (16% organic) in Q125, affected by technical challenges over the integration and unification onto a single... ► Artikel lesen | ||
| 22.08. | PORR Group - Strong order growth set to continue | 563 | PORR Group delivered new orders of €2,510m in Q225 (up 31% y-o-y), driven by several large transport infrastructure project wins. Q225 book-to-bill rose to 1.5x and the order book now stands at €9,421m... ► Artikel lesen | ||
| 22.08. | International Airlines Group - Resilient growth | 456 | International Airlines Group's (IAG's) H125 results show strong profit growth, expansion in industry-leading margins and solid shareholder returns. Revenue growth is being driven by its premium brands... ► Artikel lesen | ||
| 22.08. | PWO Group - Focus remains on long-term growth potential | 556 | In H125, PWO's revenues and EBIT margins were lower, mainly due to weak automotive markets. So far, the company has had no problems with the import tariff situation, but it has noticed a slowdown in... ► Artikel lesen | ||
| 22.08. | Mendus - Steady progress throughout Q225 | 304 | Mendus's Q225 results reflect a period of progress across the pipeline. The lead programme, vididencel in acute myeloid leukaemia (AML), remains on track to be pivotal-stage ready in H225, creating... ► Artikel lesen | ||
| 22.08. | Herantis Pharma - H125 results reflect Phase Ib progress | 323 | Herantis Pharma has presented its H125 results, which reflect a period of steady progress as its Phase Ib trial, evaluating HER-096 in patients with Parkinson's disease (PD), edges closer to completion.... ► Artikel lesen | ||
| 21.08. | Picton Property Income - A 13.5% Q1 shareholder return | 264 | Picton Property Income (PCTN) delivered a 1.9% NAV total return in Q126, a combination of dividends (116% covered by EPRA earnings) and modest NAV growth. Lease events continue to unlock reversionary... ► Artikel lesen | ||
| 21.08. | NFON - H125 - a reminder that patience is required | 423 | Investors viewing NFON purely as a growth story might well be disappointed in its modest Q225 top-line growth, but they would be missing other factors. NFON is still in the final stages of a multi-year... ► Artikel lesen | ||
| 21.08. | Gresham House Energy Storage Fund - Debt refinancing unlocks growth potential | 238 | On 18 August 2025, Gresham House Energy Storage Fund (GRID) announced the signing of a new debt facility to refinance existing facilities. This reduces the fund's cost of debt and releases capital for... ► Artikel lesen | ||
| 21.08. | Mendus - Clinical activities on track | 291 | Mendus has reported its Q225 results. During the period, it made continued progress on the lead programme (vididencel in acute myeloid leukaemia, AML), which remains on track to be pivotal-stage ready... ► Artikel lesen | ||
| 19.08. | Nanoco Group - Encouraging commercial progress continues | 336 | Nanoco's trading update indicates that the business is making encouraging commercial progress since Dmitry Shashkov took over as CEO in October 2024. If all goes to plan, this should result in further... ► Artikel lesen |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .